Researchers identify potential new leukemia drug target
10/23/2015
New treatment options are badly needed for acute myeloid leukemia, a relatively rare form of cancer.
Allina Health study could save breast cancer patients time, money and side effects
10/23/2015
Most with invasive lobular carcinoma could be treated with hormones aloneMost breast cancer patients with invasive lobular carcinoma could be treated with hormones alone and not with...
Monitoring critical blood levels in real time in the ICU
10/23/2015
EPFL has developed a miniaturized microfluidic device that will allow medical staff to monitor in real time levels of glucose, lactate a.s.o.
Study combats 'anxiety' as barrier to breast cancer screening
10/23/2015
Recent American Cancer Society (ACS) breast cancer screening guidelines consider the anxiety created by false-positive mammography an "important but not critical outcome" when deciding who should be...
New gene a key to fighting sepsis
10/23/2015
Scientists have identified a gene that could potentially open the door for the development of new treatments of the lethal disease sepsisScientists have identified a gene that could potentially...
MAMMOCARE Project achieves earlier and more accurate breast cancer diagnosis
10/22/2015
Breast cancer is by far the most frequent cancer among women, and one of the leading causes of cancer-related mortality and early diagnosis is essential to reduce the risk of mortality.
MAMMOCARE Project achieves earlier and more accurate breast cancer diagnosis
10/22/2015
Breast cancer is by far the most frequent cancer among women, and one of the leading causes of cancer-related mortality and early diagnosis is essential to reduce the risk of mortality.
FDA approves new drug to treat hyperkalemia
10/22/2015
The U.S. Food and Drug Administration has approved Veltassa (patiromer for oral suspension) to treat hyperkalemia, a serious condition in which the amount of potassium in the blood is too high.
FDA approves new drug to treat hyperkalemia
10/22/2015
The U.S. Food and Drug Administration has approved Veltassa (patiromer for oral suspension) to treat hyperkalemia, a serious condition in which the amount of potassium in the blood is too high.
Scientists design more effective approach to deliver drugs targeting cancer cells and other diseases
10/22/2015
Scientists have designed a novel method for improving the delivery of therapeutic molecules into diseased cells such as those found in cancer and tuberculosis.